Nancy Hutson

(Dr. Nancy Hutson Ph.D.)

Currently holds positions in Clearside Biomedical Inc and BioCryst Pharmaceuticals Inc

Positions

Position Company Period
Director Clearside Biomedical Inc April 21, 2020 -
Independent Director BioCryst Pharmaceuticals Inc Jan. 20, 2012 -
Independent Director Cubist Pharmaceuticals LLC June 12, 2008 - Jan. 21, 2015
Nancy Hutson's trades of BioCryst Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-13
PS Planned sale
7,000 -7.5%
7.54
USD 52,780 		7,000 -7.5% 7.54 USD 52,780
2024-05-22 2024-05-20
B Purchase
5,000 +6.1%
6.38
USD 31,900 		5,000 +6.1% 6.38 USD 31,900
2023-10-04 2023-10-03
B Purchase
10,000 +12.0%
0.86
USD 8,600 		10,000 +12.0% 0.86 USD 8,600
2023-06-15 2023-06-14
S Sale
12,866 -13.6%
8.04
USD 103,443 		12,866 -13.6% 8.04 USD 103,443
2022-11-21 2022-11-17
B Purchase
30,000 +56.6%
1.33
USD 39,900 		30,000 +56.6% 1.33 USD 39,900
2021-10-19 2021-10-15
PS Planned sale
105,000 -61.7%
15.40
USD 1,617,000 		105,000 -61.7% 15.40 USD 1,617,000
2021-08-17 2021-08-16
B Purchase
3,000 +30.0%
5.68
USD 17,040 		3,000 +30.0% 5.68 USD 17,040
2021-06-14 2021-06-10
PS Planned sale
23,333 -26.4%
16.86
USD 393,394 		23,333 -26.4% 16.86 USD 393,394
2021-03-15 2021-03-12
B Purchase
5,000 +100.0%
3.11
USD 15,525 		5,000 +100.0% 3.11 USD 15,525
2020-05-21 2020-05-20
B Purchase
5,000 +inf%
1.85
USD 9,250 		5,000 +inf% 1.85 USD 9,250
2018-12-17 2018-12-17
B Purchase
1,000 +inf%
4.46
USD 4,460 		1,000 +inf% 4.46 USD 4,460
// ... existing code ... // ... rest of the file ...